Amgen
Amgen is seeking a Senior Scientist (Organic Chemist) to develop next-generation RNA therapeutics and expand synthetic capabilities within the Genetic Medicines group. The role involves designing and preparing novel delivery ligands, conjugation linkers, and nucleotides to chemically modify oligonucleotides for enhanced delivery and efficacy. Candidates will perform hands-on synthesis at mg-to-gram scales, optimize protocols, and collaborate with cross-functional teams to advance the therapeutic RNA pipeline.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
6% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Synthetic DNA Process Development Scientist
Eurofins
Senior Scientist Synthetic Chemist In Oligonucleotide Therapeutics M%C3%B6lndal Sweden
AstraZeneca
Senior Scientist (Synthetic Chemistry)
AstraZeneca
Associate Oligonucleotide Chemist
Eli Lilly and Company
PhD‑Level Scientist – Oligonucleotide Synthesis Lead
Novartis
PhD‑Level Scientist – Oligonucleotide Synthesis Lead
Novartis